Stockreport

Humacyte (HUMA) Is Down 25.7% After Reporting Strong Symvess Trauma Results and Completing $60M Equity Raise [Yahoo! Finance]

Humacyte, Inc.  (HUMA) 
PDF Ukraine, showing high patency, zero infections, and 100% limb salvage in trauma patients, alongside an oversubscribed US$60.0 million direct equity offering consisting o [Read more]